TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
劉宗灝LIU, TSUNG-HAO
- 計畫主持人
- 執行臨床試驗年資 12 年 9 個月
-
thliu@ntuh.gov.tw
發表文獻
8筆
1
Liu TH, Shao YY, Hsu CH. It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade. J Formos Med Assoc. 2021 Jan;120(1 Pt 1):1-4. doi: 10.1016/j.jfma.2020.07.009. Epub 2020 Jul 11. PMID: 32660891.
2
Dong Y, Liu TH, Yau T, Hsu C. Novel systemic therapy for hepatocellular carcinoma. Hepatol Int. 2020 Sep;14(5):638-651. doi: 10.1007/s12072-020-10073-7. Epub 2020 Jul 13. PMID: 32661949.
3
Lee MR, Yu KL, Kuo HY, Liu TH, Ko JC, Tsai JS, Wang JY. Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study. Sci Rep. 2019 Jul 1;9(1):9478. doi: 10.1038/s41598-019-45977-4. PMID: 31263137; PMCID: PMC6602946.
4
Liu TH, Shao YY, Lu LC, Shen YC, Hsu C, Lin ZZ, Hsu CH, Cheng AL. Considerations of heterogeneity in clinical trials for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):615-621. doi: 10.1080/17474124.2019.1621165. Epub 2019 May 27. PMID: 31132887.
5
Shao YY, Liu TH, Hsu C, Lu LC, Shen YC, Lin ZZ, Cheng AL, Hsu CH. Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma. Liver Int. 2019 Nov;39(11):2184-2189. doi: 10.1111/liv.14210. Epub 2019 Aug 31. PMID: 31400295.
6
Lu LC, Lee YH, Chang CJ, Shun CT, Fang CY, Shao YY, Liu TH, Cheng AL, Hsu CH. Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment. Liver Cancer. 2019 Mar;8(2):110-120. doi: 10.1159/000489021. Epub 2018 Jun 15. PMID: 31019901; PMCID: PMC6465685.
7
Lu LC, Hsu C, Shao YY, Chao Y, Yen CJ, Shih IL, Hung YP, Chang CJ, Shen YC, Guo JC, Liu TH, Hsu CH, Cheng AL. Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Liver Cancer. 2019 Nov;8(6):480-490. doi: 10.1159/000501275. Epub 2019 Aug 6. PMID: 31799205; PMCID: PMC6883443.
8
Liu TH, Hsu CH, Shao YY. Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure. Liver Cancer. 2018 May;7(2):205-208. doi: 10.1159/000486763. Epub 2018 Apr 20. PMID: 29888209; PMCID: PMC5985408.
